Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Rheumatoid | 5 | 2010 | 136 | 0.870 |
Why?
|
| Antirheumatic Agents | 4 | 2010 | 57 | 0.630 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 79 | 0.300 |
Why?
|
| Methotrexate | 1 | 2006 | 36 | 0.250 |
Why?
|
| Stomach Diseases | 1 | 2006 | 4 | 0.240 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2006 | 25 | 0.230 |
Why?
|
| Proton Pump Inhibitors | 1 | 2006 | 27 | 0.230 |
Why?
|
| Sulfonamides | 1 | 2006 | 73 | 0.220 |
Why?
|
| Pyrazoles | 1 | 2006 | 80 | 0.220 |
Why?
|
| Aspirin | 1 | 2006 | 125 | 0.220 |
Why?
|
| Education, Pharmacy | 3 | 2011 | 124 | 0.200 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 351 | 0.190 |
Why?
|
| Educational Measurement | 2 | 2011 | 142 | 0.150 |
Why?
|
| Curriculum | 2 | 2011 | 307 | 0.140 |
Why?
|
| Hyperkalemia | 1 | 1995 | 8 | 0.120 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1995 | 10 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1995 | 22 | 0.120 |
Why?
|
| Anti-Infective Agents | 1 | 1995 | 78 | 0.110 |
Why?
|
| Problem-Based Learning | 2 | 2011 | 62 | 0.100 |
Why?
|
| Humans | 12 | 2011 | 29202 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 1994 | 336 | 0.090 |
Why?
|
| Tolmetin | 1 | 1990 | 2 | 0.080 |
Why?
|
| Tromethamine | 1 | 1990 | 2 | 0.080 |
Why?
|
| Remission Induction | 1 | 2010 | 58 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 116 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2006 | 2442 | 0.080 |
Why?
|
| Disease Progression | 1 | 2010 | 483 | 0.070 |
Why?
|
| Accreditation | 1 | 2008 | 37 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 46 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2010 | 632 | 0.070 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2007 | 14 | 0.070 |
Why?
|
| Rheumatology | 1 | 2007 | 18 | 0.070 |
Why?
|
| Sulfasalazine | 1 | 2006 | 2 | 0.060 |
Why?
|
| Pharmacists | 1 | 2007 | 74 | 0.060 |
Why?
|
| Isoxazoles | 1 | 2006 | 8 | 0.060 |
Why?
|
| Hydroxychloroquine | 1 | 2006 | 20 | 0.060 |
Why?
|
| Time Factors | 1 | 2010 | 1619 | 0.060 |
Why?
|
| Celecoxib | 1 | 2006 | 10 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 210 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2006 | 106 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2006 | 414 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 252 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 149 | 0.050 |
Why?
|
| Decision Making | 1 | 2006 | 179 | 0.050 |
Why?
|
| Pharmacology, Clinical | 2 | 2008 | 4 | 0.040 |
Why?
|
| Societies, Pharmaceutical | 2 | 2008 | 5 | 0.040 |
Why?
|
| Preceptorship | 2 | 2008 | 22 | 0.040 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1995 | 3 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1995 | 10 | 0.030 |
Why?
|
| Potassium | 1 | 1995 | 43 | 0.030 |
Why?
|
| Aged | 1 | 2006 | 5647 | 0.030 |
Why?
|
| Recurrence | 1 | 1995 | 328 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 1994 | 19 | 0.030 |
Why?
|
| Middle Aged | 1 | 2006 | 7493 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1994 | 75 | 0.030 |
Why?
|
| Antigens, CD | 1 | 1994 | 140 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1993 | 23 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1994 | 221 | 0.020 |
Why?
|
| United States | 2 | 2008 | 2269 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 112 | 0.020 |
Why?
|
| Ketorolac Tromethamine | 1 | 1990 | 3 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1990 | 22 | 0.020 |
Why?
|
| Half-Life | 1 | 1990 | 34 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1990 | 37 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1990 | 51 | 0.020 |
Why?
|
| Students, Pharmacy | 1 | 2011 | 91 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1990 | 79 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1990 | 613 | 0.020 |
Why?
|
| Professional Role | 1 | 2007 | 46 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1990 | 1213 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 316 | 0.010 |
Why?
|
| Mice | 1 | 1994 | 4867 | 0.010 |
Why?
|
| Child | 1 | 1990 | 2354 | 0.010 |
Why?
|
| Adult | 1 | 1995 | 8125 | 0.010 |
Why?
|
| Animals | 1 | 1994 | 10802 | 0.010 |
Why?
|
| Male | 1 | 1995 | 14120 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1993 | 426 | 0.010 |
Why?
|
Resman-Targoff's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(77)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(57)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_